As of 2025-09-16, the EV/EBITDA ratio of Rapid Dose Therapeutics Corp (DOSE.CN) is -6.24. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. DOSE.CN's latest enterprise value is 24.51 mil CAD. DOSE.CN's TTM EBITDA according to its financial statements is -3.93 mil CAD. Dividing these 2 quantities gives us the above DOSE.CN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 5.6x - 8.3x | 7.0x |
| Forward P/E multiples | 7.2x - 10.8x | 9.0x |
| Fair Price | (0.23) - (0.27) | (0.26) |
| Upside | -240.9% - -261.4% | -254.8% |
| Date | EV/EBITDA |
| 2025-09-10 | -6.40 |
| 2025-09-09 | -6.07 |
| 2025-09-08 | -6.74 |
| 2025-09-05 | -6.74 |
| 2025-09-04 | -6.40 |
| 2025-09-03 | -6.91 |
| 2025-09-02 | -6.40 |
| 2025-08-27 | -6.57 |
| 2025-08-26 | -6.57 |
| 2025-08-25 | -6.57 |
| 2025-08-22 | -6.91 |
| 2025-08-21 | -6.74 |
| 2025-08-19 | -6.74 |
| 2025-08-18 | -7.25 |
| 2025-08-15 | -6.74 |
| 2025-08-14 | -6.74 |
| 2025-08-13 | -6.91 |
| 2025-08-12 | -6.74 |
| 2025-08-11 | -7.08 |
| 2025-08-08 | -6.40 |
| 2025-08-07 | -6.91 |
| 2025-08-06 | -6.57 |
| 2025-08-05 | -6.74 |
| 2025-08-01 | -6.57 |
| 2025-07-31 | -6.91 |
| 2025-07-30 | -6.91 |
| 2025-07-29 | -6.74 |
| 2025-07-28 | -7.08 |
| 2025-07-25 | -6.74 |
| 2025-07-24 | -7.42 |
| 2025-07-23 | -7.25 |
| 2025-07-22 | -7.08 |
| 2025-07-21 | -7.08 |
| 2025-07-17 | -7.25 |
| 2025-07-16 | -7.08 |
| 2025-07-15 | -7.42 |
| 2025-07-14 | -7.42 |
| 2025-07-11 | -8.43 |
| 2025-07-10 | -7.76 |
| 2025-07-09 | -7.42 |
| 2025-07-08 | -7.08 |
| 2025-07-07 | -6.91 |
| 2025-07-04 | -6.74 |
| 2025-07-03 | -7.42 |
| 2025-07-02 | -7.42 |
| 2025-06-30 | -6.91 |
| 2025-06-27 | -7.76 |
| 2025-06-26 | -7.42 |
| 2025-06-24 | -7.42 |
| 2025-06-23 | -7.08 |